Advanced Transit Dynamics News

This week's multi-billion dollar corporate bond offerings from Microsoft, CVS Caremark and Johnson & Johnson pushed the volume of US non-financial investment grade corporate debt to $438.0 billion for year-to-date 2013, a 6% increase compared to a year ago and the strongest year-to-date period on record.

The firm currently has a $61.00 target price on the stock, up from their previous target price of $45.00.

Janis Plostnieks, 80, of Blue Bell, a corporate chemist and executive at Johnson & Johnson for many years, died Friday, Nov. 29, of cancer at Holy Redeemer Hospital.

Johnson & Johnson officials destroyed or misplaced documents related to its vaginal-mesh implants and should be barred from relying on some defenses in planned trials over the devices, patients' lawyers said.

Johnson & Johnson and Bayer's drug Xarelto generated $246 million in sales in the third quarter, while sales of Eliquis from Pfizer and Bristol-Myers Squibb were $41 million for the same period.

Johnson & Johnson, the AAA rated maker of health-care products from Band-Aids to Listerine, sold $3.5 billion of bonds in its first offering since 2011.

Under a recent settlement, medical insurers may receive $1 billion from Johnson & Johnson for covering the cost of removing recalled hip implants.

However, over the past year, shares of the diversified medical giant have climbed 34% -- outperforming both the market and most of its big-pharma industry peers.

Johnson & Johnson companies are equal opportunity employers. Territory Manager - Boston, MA - Biosense Webster, Inc.-5885130715 Description Biosense Webster, a member of Johnson & Johnson's Family of Companies, is recruiting for a Territory Manager, to cover the Boston, MA territory.

Same with stocks. The great ones don't stay great forever. Look at Microsoft , Johnson & Johnson , Merck , Cisco , General Electric .

TORONTO , Nov. 25, 2013 /CNW/ - MaRS Innovation , a Centre of Excellence for Commercialization and Research, today announced a new collaboration with Johnson & Johnson Innovation and its affiliate Janssen, Inc. , in Canada to advance early-stage technologies related to human health in therapeutics, medical devices, and diagnostics.

GMO, the $112 billion investment management firm led by chief investment strategist Jeremy Grantham is out with its latest quarterly letter and the news remains the same: stocks, in general, are not at all compelling.

MARK COLVIN: Hundreds of women have joined a class action against the medical giant Johnson and Johnson over a range of their products.

After decades of Hepatitis C claims that there is no viable treatment, other than the regularly prescribed antiviral medication, Johnson and Johnson has come up with a drug to inhibit and eliminate Hep C altogether.

The U.S. Food and Drug Administration said Friday it approved the drug, a protease inhibitor that blocks a protein needed by the virus to replicate.

Expectant mothers often take Tylenol, with the active ingredient acetaminophen, to deal with back pain, headaches or mild fevers during pregnancy.

Kaiser Gornick LLP Announces Settlement of DePuy ASR Cases and Appointment of Lawrence J. Gornick to the Settlement Oversight Committee SAN FRANCISCO, CA, USA, November 22, 2013 / EINPresswire.com / -- DePuy Orthopaedics, Inc., a subsidiary of Johnson & Johnson, has agreed to settle approximately 8,000 ASR hip replacement claims for $2.475 billion.

EU antitrust regulators are set to fine Johnson & Johnson and Novartis next month as part of a crackdown against deals delaying the sale of cheaper generic medicines, two people familiar with the matter said on Friday.

Growing Stock Report expands its NYSE Active Stock Weekly Watch List adding Deere & Company and Johnson & Johnson .

Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing thesis.